Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 2 (2005), Issue 6 (June)

1. The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals.
   Cancer Res, 65(11): 4520-4. [Abstract] [Full-text]
2. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.
   Oncogene, 24(24): 3896-905. [Abstract] [Full-text]
3. Patient perceptions of "awake" brain tumour surgery.
   Acta Neurochir (Wien), 147(3): 275-7; discussion 277. [Abstract] [Full-text]
4. Treatment outcomes and mortality of 94 patients with acromegaly.
   Acta Neurochir (Wien), 147(3): 243-51; discussion 250-1. [Abstract] [Full-text]
5. Rare fatal vascular complication of transsphenoidal surgery.
   Acta Neurochir (Wien), 147(3): 321-5; discussion 325. [Abstract] [Full-text]
6. Cerebral neurocytoma without ganglion cell differentiation.
   Acta Neurochir (Wien), 147(3): 309-12; discussion 312. [Abstract] [Full-text]
7. Delayed occurrence of intracranial supratentorial chondroma following compound depressed skull fracture.
   Acta Neurochir (Wien), 147(3): 343-5; discussion 345. [Abstract] [Full-text]
8. Vanishing pituitary mass revealed by timely magnetic resonance imaging: examples of spontaneous resolution of nonfunctioning pituitary adenoma.
   Acta Neurochir (Wien), 147(3): 253-7; discussion 257. [Abstract] [Full-text]
9. Evaluation of vascular supply with angio-computed tomography during intra-arterial chemotherapy for brain tumors.
   Cardiovasc Intervent Radiol, 28(3): 354-7. [Abstract] [Full-text]
10. Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.
    Onkologie, 28(6): 325-30. [Abstract] [Full-text]
11. Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons.
    Exp Brain Res, 160(1): 89-106. [Abstract] [Full-text]
12. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index.
    J Neurooncol, 72(3): 273-80. [Abstract] [Full-text]
13. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
    J Neurooncol, 72(3): 261-5. [Abstract] [Full-text]
14. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.
    J Neurooncol, 72(3): 255-60. [Abstract] [Full-text]
15. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.
    J Neurooncol, 72(3): 245-53. [Abstract] [Full-text]
16. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    J Neurooncol, 72(3): 241-4. [Abstract] [Full-text]
17. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    J Neurooncol, 72(3): 231-8. [Abstract] [Full-text]
18. Comparative genomic hybridization and mutation analyses of sporadic schwannomas.
    J Neurooncol, 72(3): 225-30. [Abstract] [Full-text]
19. Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.
    J Neurooncol, 72(3): 217-23. [Abstract] [Full-text]
20. Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases.
    J Neurooncol, 72(3): 209-15. [Abstract] [Full-text]
21. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
    Int J Radiat Oncol Biol Phys, 62(3): 797-802. [Abstract] [Full-text]
22. Extremely rare glioblastoma multiforme of the conus medullaris with holocord and brain stem metastases, leading to cranial nerve deficit and respiratory failure: a case report and review of the literature.
    Surg Neurol, 63(6): 576-82; discussion 582-3. [Abstract] [Full-text]
23. Intradural dermoid tumor of the posterior fossa in a child with diastematobulbia.
    Surg Neurol, 63(6): 571-5; discussion 575. [Abstract] [Full-text]
24. Incidental findings in brain computed tomography scans of 3000 head trauma patients.
    Surg Neurol, 63(6): 550-3; discussion 553. [Abstract] [Full-text]
25. Correlation of factors predicting intraoperative brain shift with successful resection of malignant brain tumors using image-guided techniques.
    Surg Neurol, 63(6): 542-8; discussion 548-9. [Abstract] [Full-text]
26. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features.
    Surg Neurol, 63(6): 520-5; discussion 525. [Abstract] [Full-text]
27. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
    Surg Neurol, 63(6): 511-9; discussion 519. [Abstract] [Full-text]
28. Molecular pathology and clinical characteristics of oligodendroglial neoplasms.
    Ann Neurol, 57(6): 855-65. [Abstract] [Full-text]
29. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Ann Neurol, 57(6): 843-7. [Abstract] [Full-text]
30. Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH).
    Neurotoxicology, 26(3): 407-16. [Abstract] [Full-text]
31. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    J Biol Chem, 280(23): 21882-92. [Abstract] [Full-text]
32. CNS recurrence following CD34+ peripheral blood stem cell transplantation in stage 4 neuroblastoma.
    Pediatr Blood Cancer, 45(1): 68-71. [Abstract] [Full-text]
33. Ewing's sarcoma and primitive neuroectodermal family of tumors.
    Hematol Oncol Clin North Am, 19(3): 501-25, vi-vii. [Abstract] [Full-text]
34. Survival of adults treated for medulloblastoma using paediatric protocols.
    Eur J Cancer, 41(9): 1304-10. [Abstract] [Full-text]
35. Cyanotic breath-holding spell: a life-threatening complication after radical resection of a cervicomedullary ganglioglioma.
    Pediatr Neurosurg, 41(2): 93-7. [Abstract] [Full-text]
36. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
    Eur J Endocrinol, 152(6): 825-33. [Abstract] [Full-text]
37. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
    Genes Chromosomes Cancer, 43(4): 329-38. [Abstract] [Full-text]
38. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Cancer, 103(12): 2606-15. [Abstract] [Full-text]
39. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
    Cancer, 103(12): 2590-7. [Abstract] [Full-text]
40. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
    Cancer, 103(12): 2598-605. [Abstract] [Full-text]
41. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.
    Cancer, 103(12): 2636-42. [Abstract] [Full-text]
42. Gamma-knife radiosurgery for the treatment of ovarian cancer metastatic to the brain.
    Gynecol Oncol, 97(3): 858-61. [Abstract] [Full-text]
43. Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors.
    Clin Endocrinol (Oxf), 62(6): 698-705. [Abstract] [Full-text]
44. Adenoid glioblastoma arising in a patient with neurofibromatosis type-1.
    Pathol Int, 55(6): 348-52. [Abstract] [Full-text]
45. Optical and MRI multifunctional nanoprobe for targeting gliomas.
    Nano Lett, 5(6): 1003-8. [Abstract] [Full-text]
46. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    J Pathol, 206(3): 328-36. [Abstract] [Full-text]
47. Enhanced protein kinase B/Akt signalling in pituitary tumours.
    Endocr Relat Cancer, 12(2): 423-33. [Abstract] [Full-text]
48. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.
    Epilepsia, 46(6): 849-57. [Abstract] [Full-text]
49. Evaluation of relation among aneurysmal neck, parent artery, and daughter arteries in middle cerebral artery aneurysms, by three-dimensional digital subtraction angiography.
    Neurosurg Rev, 28(3): 196-200. [Abstract] [Full-text]
50. Cystic versus solid vestibular schwannomas: a series of 80 grade III-IV patients.
    Neurosurg Rev, 28(3): 209-13. [Abstract] [Full-text]
51. Low-grade primary meningeal lymphoma: case report and review of the literature.
    Neurosurg Rev, 28(3): 229-33. [Abstract] [Full-text]
52. Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.
    Breast Cancer Res Treat, 91(3): 217-25. [Abstract] [Full-text]
53. An unusual case of Turcot's syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin's lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot's syndrome.
    Fam Cancer, 4(2): 139-43. [Abstract] [Full-text]
54. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Brain Res Mol Brain Res, 137(1): 98-103. [Abstract] [Full-text]
55. Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas.
    Brain Res Mol Brain Res, 137(1): 77-88. [Abstract] [Full-text]
56. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    Neurol Res, 27(4): 387-98. [Abstract] [Full-text]
57. Expression of VEGF and its receptors in different brain tumors.
    Neurol Res, 27(4): 371-7. [Abstract] [Full-text]
58. An adaptive level set method for interactive segmentation of intracranial tumors.
    Neurol Res, 27(4): 363-70. [Abstract] [Full-text]
59. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen.
    Neurol Res, 27(4): 358-62. [Abstract] [Full-text]
60. Evaluation of intra-operative ultrasound imaging in brain tumor resection: a prospective study.
    Neurol Res, 27(4): 351-7. [Abstract] [Full-text]
61. Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.
    Brain Res, 1047(1): 56-64. [Abstract] [Full-text]
62. A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline.
    Headache, 45(5): 604-6. [Abstract] [Full-text]
63. Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands.
    Mol Cell Endocrinol, 238(1): 51-5. [Abstract] [Full-text]
64. Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A.
    Mol Cell Endocrinol, 238(1): 57-67. [Abstract] [Full-text]
65. No prognostic impact of survivin expression in glioblastoma.
    Acta Neuropathol (Berl), 109(5): 534-8. [Abstract] [Full-text]
66. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Oncogene, 24(22): 3596-605. [Abstract] [Full-text]
67. Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.
    Childs Nerv Syst, 21(6): 477-81. [Abstract] [Full-text]
68. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
    J Natl Cancer Inst, 97(12): 880-7. [Abstract] [Full-text]
69. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
    Cancer Res, 65(12): 5428-38. [Abstract] [Full-text]
70. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Cancer Res, 65(12): 5190-4. [Abstract] [Full-text]
71. Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.
    Cancer Res, 65(12): 5172-80. [Abstract] [Full-text]
72. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
    Cancer Res, 65(12): 4975-8. [Abstract] [Full-text]
73. Risk factors from brain tumors in children and adolescents: a case-control study in Belgrade, Serbia.
    Eur J Neurol, 12(7): 508-13. [Abstract] [Full-text]
74. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
    Nephrology (Carlton), 10(3): 321-4. [Abstract] [Full-text]
75. Novel platinum(IV) complexes induce rapid tumor cell death in vitro.
    Int J Cancer, 116(3): 479-86. [Abstract] [Full-text]
76. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Cancer Gene Ther, 12(7): 655-62. [Abstract] [Full-text]
77. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
    Cancer Gene Ther, 12(7): 600-7. [Abstract] [Full-text]
78. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
    J Clin Oncol, 23(18): 4127-36. [Abstract] [Full-text]
79. The role of dominant striatum in language: a study using intraoperative electrical stimulations.
    J Neurol Neurosurg Psychiatry, 76(7): 940-6. [Abstract] [Full-text]
80. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics.
    Lancet Neurol, 4(7): 413-22. [Abstract] [Full-text]
81. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
    Clin Endocrinol (Oxf), 63(1): 39-44. [Abstract] [Full-text]
82. Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.
    Clin Endocrinol (Oxf), 63(1): 26-31. [Abstract] [Full-text]
83. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.
    Ann Oncol, 16(7): 1177-84. [Abstract] [Full-text]
84. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Oncogene, 24(25): 4026-36. [Abstract] [Full-text]
85. New irradiation geometry for microbeam radiation therapy.
    Phys Med Biol, 50(13): 3103-11. [Abstract] [Full-text]
86. Analysis of secretory, immunostaining and clinical characteristics of human "functionless" pituitary adenomas: transdifferentiation or gonadotropinomas?
    Exp Clin Endocrinol Diabetes, 113(6): 344-9. [Abstract] [Full-text]
87. No GIST-type c-kit gain of function mutations in neuroblastic tumours.
    J Clin Pathol, 58(7): 762-5. [Abstract] [Full-text]
88. Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature.
    J Neurooncol, 73(3): 273-5. [Abstract] [Full-text]
89. An unusual complication of cancer treatment for acute lymphoblastic leukemia.
    J Neurooncol, 73(3): 269-72. [Abstract] [Full-text]
90. Paraganglioma in sella.
    J Neurooncol, 73(3): 265-7. [Abstract] [Full-text]
91. Primary malignant rhabdoid tumor of the central nervous system--a comprehensive review.
    J Neurooncol, 73(3): 241-52. [Abstract] [Full-text]
92. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
    J Neurooncol, 73(3): 225-38. [Abstract] [Full-text]
93. Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study.
    J Neurooncol, 73(3): 211-7. [Abstract] [Full-text]
94. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.
    J Neurooncol, 73(3): 205-9. [Abstract] [Full-text]
95. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.
    J Neurooncol, 73(3): 189-98. [Abstract] [Full-text]
96. Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
    Neurol Res, 27(5): 516-21. [Abstract] [Full-text]
97. Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging.
    Magn Reson Med, 54(1): 87-95. [Abstract] [Full-text]
98. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.
    Cancer, 104(1): 143-8. [Abstract] [Full-text]
99. Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients.
    Cancer, 104(1): 126-34. [Abstract] [Full-text]
100. Recurrent central neurocytomas.
     Cancer, 104(1): 135-42. [Abstract] [Full-text]
101. Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma.
     Pathol Int, 55(7): 377-85. [Abstract] [Full-text]
102. PIK3CA mutations in glioblastoma multiforme.
     Acta Neuropathol (Berl), 109(6): 639-42. [Abstract] [Full-text]
103. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas.
     Acta Neuropathol (Berl), 109(6): 598-602. [Abstract] [Full-text]
104. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
     Acta Neuropathol (Berl), 109(6): 589-97. [Abstract] [Full-text]
105. Biological evaluation of penetration domain and killing domain peptides.
     J Gene Med, 7(7): 908-17. [Abstract] [Full-text]
106. High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.
     NMR Biomed, 18(4): 252-9. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.